Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for Alignment Healthcare (ALHC) over the last 4 years, with Q3 2025 value amounting to $199.0 million.

  • Alignment Healthcare's Shares Outstanding (Weighted Average) rose 400.58% to $199.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $199.0 million, marking a year-over-year increase of 400.58%. This contributed to the annual value of $190.8 million for FY2024, which is 245.89% up from last year.
  • According to the latest figures from Q3 2025, Alignment Healthcare's Shares Outstanding (Weighted Average) is $199.0 million, which was up 400.58% from $198.3 million recorded in Q2 2025.
  • Alignment Healthcare's Shares Outstanding (Weighted Average)'s 5-year high stood at $199.0 million during Q3 2025, with a 5-year trough of $181.2 million in Q4 2022.
  • For the 4-year period, Alignment Healthcare's Shares Outstanding (Weighted Average) averaged around $189.7 million, with its median value being $189.9 million (2024).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 215.29% in 2024, then skyrocketed by 400.58% in 2025.
  • Alignment Healthcare's Shares Outstanding (Weighted Average) (Quarter) stood at $181.2 million in 2022, then increased by 2.76% to $186.2 million in 2023, then rose by 2.46% to $190.8 million in 2024, then rose by 4.32% to $199.0 million in 2025.
  • Its last three reported values are $199.0 million in Q3 2025, $198.3 million for Q2 2025, and $193.6 million during Q1 2025.